Shattuck Labs, Inc. Common Stock

STTKNASDAQ • USD
4.57 USD
↘ 0.09 (1.93%)🟢PRE MARKET (AS OF 07:53 AM EST)
🟢Market: OPEN

Shattuck Labs, Inc. Common Stock (STTK) is currently trading at $4.57. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$4.66
High?$4.66
Low?$4.08
Prev. Close?$4.66
Volume?95
Avg. Volume?1.1M
VWAP?$4.38
Rel. Volume?0.00x
Bid / Ask
Bid?$3.79 × 100
Ask?$5.59 × 100
Spread?$1.80
Midpoint?$4.69
Valuation & Ratios
Market Cap?474.6M
Shares Out?101.8M
Float?78.9M
Float %?78.6%
P/E Ratio?N/A
P/B Ratio?2.45
EPS?-$0.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Employees
40
Market Cap
473.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-09
Address
500 W. 5TH STREET
AUSTIN, TX 78701
Phone: 512-900-4690
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?16.57Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?13.62%High
Short Interest?10.7M
Days to Cover?12.0
Free Float78.9M
Avg Daily Volume898.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?15.80Strong
Quick Ratio?15.80Strong
Cash Ratio?4.84Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
65
2.45CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
5
-35.0%WEAK▾
ROA?
S&P
3
-32.6%WEAK▾
Cash Flow & Enterprise
FCF?$-49760000
Enterprise Value?$412.8M
Fundamentals ratios updated end of day